TORONTO, March 31 /PRNewswire-FirstCall/ -- MedCap Corp (Pinksheets: MPCPF) is pleased to announce that its AccuScan Heroin/Morphine test kit has been given experimental status for testing purposes and is being used in several hospitals in the Beijing area as well as being used by law enforcement agencies for testing individuals who are known to use illegal substances. Authorities have been pleased with the performance to date.
This kit has been submitted for regulatory approval in China. Based on meetings with representatives of the regulatory bodies, it is anticipated that this kit will receive approval in approximately 60 days. As a result of the interest in all of the AccuScan kits by the regulatory agencies, the Company will begin the approval process in China for the other AccuScan test kits.
MedCap Corp trades in the United States on the Pinksheets under the symbol "MPCPF".
For further information, please contact Cazgeld Capital Corporation at (416) 363 0070 or at http://www.medccorp.com/.
This release may contain forward-looking statements that involve uncertainties and risks. Actual results may differ materially from any results predicted. MedCap undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events of circumstances after the date hereof.
CONTACT: Cazgeld Capital Corporation at (416) 363 0070